HIBT Lab! Immunai: Noam Solomon

HIBT Lab! Immunai: Noam Solomon

According to the CDC, 6 in 10 adults in the U.S. have a chronic disease like cancer or diabetes. Meanwhile, the process for discovering new drug treatments is critically expensive and inefficient. About 90% of drug candidates fail to gain FDA approval; the average cost to develop a new drug is over $1 billion; and testing can take over 10 years.


Noam Solomon is on a mission to change this. His company, Immunai, is using artificial intelligence to create an atlas of the human immune system.


This week on How I Built This Lab, Guy talks with Noam about how Immunai’s immune system mapping is accelerating the development of new personalized drug therapies. Plus, Noam shares how Immunai’s culture of ‘not knowing’ drives scientific innovation.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episoder(803)

Advice Line with Jonathan Neman of Sweetgreen

Advice Line with Jonathan Neman of Sweetgreen

Sweetgreen’s co-founder Jonathan Neman joins Guy on the Advice Line to answer questions from three early-stage founders. Plus, Sweetgreen’s plans to automate salad assembly in the coming years. First,...

24 Apr 202548min

Snap: Evan Spiegel

Snap: Evan Spiegel

What started as a design project for Stanford student Evan Spiegel quickly flourished into one of the most-used social media platforms in the world: Snapchat. It only took two years for Mark Zuckerber...

21 Apr 20251h 6min

Advice Line with Andy Dunn of Bonobos

Advice Line with Andy Dunn of Bonobos

Bonobos co-founder Andy Dunn joins Guy on the Advice Line to answer questions from three early-stage founders. Plus, Andy shares the motivation for his latest venture, Pie—a new social app that foster...

17 Apr 202548min

Vizio: William Wang

Vizio: William Wang

When Wiliam Wang started selling flat-screen TV’s, he used a winning playbook: partner with an efficient manufacturer, cut out the middlemen, and price your product as low as you can. William used a s...

14 Apr 202557min

Advice Line with Peter Rahal of RXBAR

Advice Line with Peter Rahal of RXBAR

RXBAR co-founder Peter Rahal joins Guy on the Advice Line, where they answer questions from three early-stage founders about positioning new products in competitive markets. Plus, Peter’s take on gett...

10 Apr 202542min

Title Nine: Missy Park (October 2021)

Title Nine: Missy Park (October 2021)

As a college basketball player, Missy Park was lucky to grow up during the early era of Title IX, the 1972 law that created new opportunities for young women in sports. But in the years before Lululem...

7 Apr 20251h 20min

Advice Line with Jeff and Curran Dandurand of Jack Black Skin Care

Advice Line with Jeff and Curran Dandurand of Jack Black Skin Care

Jack Black Skin Care co-founders Jeff and Curran Dandurand join Guy on the Advice Line to answer questions from three early-stage founders. Plus, how the Dandurands are passing the entrepreneurial tor...

3 Apr 202548min

Misfits Market: Abhi Ramesh

Misfits Market: Abhi Ramesh

While apple picking on a farm near Philadelphia, Abhi Ramesh learned that a massive amount of “misfit” produce goes to waste. He started running ads on Facebook to see if people would pay a discount f...

31 Mar 20251h 5min

Populært innen Business og økonomi

dine-penger-pengeradet
stopp-verden
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
lydartikler-fra-aftenposten
finansredaksjonen
pengesnakk
tid-er-penger-en-podcast-med-peter-warren
utbytte
pengepodden-2
morgenkaffen-med-finansavisen
rss-markedspuls-2
livet-pa-veien-med-jan-erik-larssen
lederpodden
okonomiamatorene
rss-investering-gjort-enkelt
stormkast-med-valebrokk-stordalen
flypodden
shifter